Clinical Trial Update: Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis [Phase 1]

View source ↗

Summary

Withdrawn Phase 1 clinical trial evaluating pharmacodynamics and safety of HGS1025 in patients with Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HGS1025

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Ulcerative Colitis | Phase 1 | Status: WITHDRAWN